KSAT 12: 94% of cancer patients respond well to COVID-19 vaccine in UT Health San Antonio study

Dimpy P. Shah, MD, PhD, of the Mays Cancer Center, was quoted in a story about a study that shows nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose.

Read story

Share This Article!